• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Short-term and long-term risk of recurrent ischemic strokes in young adults by cause

bySoroush NedaieandAlex Chan
March 1, 2024
in Cardiology, Chronic Disease, Neurology
Reading Time: 2 mins read
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Share on FacebookShare on Twitter

1. In a cohort of young patients with a first-ever stroke, the cumulative 6-month and 5-year risk of any recurrent vascular event was 6.7% and 12.2%, respectively.

2. Elevated short-term risk of recurrence was significantly higher for patients with cervical artery dissection (CeAD), atherothrombotic stroke, other rare causes of stroke, and hypertension.

3. Elevated long-term risk of recurrence was significantly higher for patients with cardioembolic stroke, a history of diabetes, and a history of alcohol abuse.

Evidence Rating Level:  2 (Good)

Over the last 2 decades, the incidence of ischemic stroke in young adults has significantly risen. There is a paucity of literature on the risk of recurrent vascular events by stroke cause in young adults, and previous research suffered from small sample sizes, outdated prevention methods, and the inclusion of patients without neuroimaging proof. This study aims to assess the short- and long-term risk of recurrent vascular events by cause and to identify high-risk subgroups of patients. Data from the prospective, multicenter Observational Dutch Young Symptomatic Stroke Study was utilized to identify and evaluate 1216 patients with an index ischemic stroke confirmed on neuroimaging (median [IQR] age, 44.2 [38.4-47.7] years; 48.0% female; median [IQR] follow-up, 4.3 [2.6-6.0] years). 137 patients (11.3%) had recurrent vascular events with 82 patients (6.7%) having their first recurrence within 6 months of their index stroke. The cumulative 6-month and 5-year incidence for any vascular event was 6.7% (95% CI, 5.3%-8.1%) and 12.2% (95% CI, 10.2%-14.2%), respectively. The incidence rate per 100 person-years for any vascular event (14.1; 95% CI, 12.6-15.6) peaked in the first 6 months post-stroke, then decreased to 1.8 (95% CI, 1.2-2.3) between 6 months and 1 year. Patients with CeAD had the highest short-term cumulative risk of any recurrent event at 13.2%, while patients with atherothrombotic stroke had the highest long-term risk of recurrence at 22.7%. In multivariate analysis, the risk of any short-term vascular event was significantly higher for patients with CeAD (HR, 4.6; P<.001, atherothrombotic stroke  (HR, 3.5; P = .02), and other rare causes of stroke (HR, 3.2; P = .008) compared with cryptogenic stroke. Hypertension was also associated with an elevated short-term risk of recurrence (HR, 2.6; P=.006). The long-term risk was significantly higher for patients with cardioembolic stroke (HR, 2.6; P=.04) compared with cryptogenic stroke and patients with a history of diabetes and alcohol abuse. Overall, a significant number of young patients experience a recurrent vascular event within 5 years,  with the cause of stroke influencing recurrence rates.

Click to read the study in JAMA Network Open

RELATED REPORTS

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Brain-predicted age difference may reliably predict dementia progression

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologycerebrovascular eventischemic strokeneurologystrokeTIA
Previous Post

Dietary niacin supplementation may reduce mortality risk in patients with non-alcoholic fatty liver disease

Next Post

Lifetime exposure to depression is associated with alterations in neural connectivity observed on functional magnetic resonance imaging

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Next Post
Children’s hospital visits for suicide ideation and attempts are increasing

Lifetime exposure to depression is associated with alterations in neural connectivity observed on functional magnetic resonance imaging

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

2 Minute Medicine Rewind March 4, 2024

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Chinese patients with advanced cancer identified 6 themes of important spiritual needs

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes
  • 2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances
  • Aletta brings autonomous robotics into routine blood collection
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in